TAKEDA PHARMACEUTICAL CO LTD
CIK 1395064 · View on SEC EDGAR ↗
- Portfolio value
- $14.1M
- Positions
- 8
- As of
- Sept. 30, 2025 Data as of Q3 2025
#8,936 of 9,443 by 13F value · top 94.6%
Portfolio value QoQ: -25.9% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 6
- Effective number of positions
- 3.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q3 2025: 1.35% Est. buys $222,845 · sells $13,902,775
Median holding: 4.0 quarters Tracked Q4 2024–Q3 2025 · 72.7% still held
- New positions
- 0
- Increased
- 1
- Decreased
- 0
- Closed
- 3
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Healthcare
93.7%
Other/Unmapped
6.3%
Full portfolio 8 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. - Common Stock | $7,475,000 | 53.19% | 5,750,000 | $5,577,500 | |||
| EQ Equillium, Inc. - Common Stock | $2,609,717 | 18.57% | 1,824,977 | $2,034,484 | |||
| XLO Xilio Therapeutics, Inc. - Common Stock | $1,243,084 | 8.85% | 1,475,121 | $240,149 | |||
| STTK Shattuck Labs, Inc. - Common Stock | $1,232,329 | 8.77% | 515,619 | $824,062 | |||
| LYELXXXX | $891,365 | 6.34% | 54,887 | $527,459 | Up ×1 | ||
| AMWL American Well Corporation Class A Common Stock | $478,061 | 3.40% | 77,733 | $-212,989 | |||
| RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | $101,554 | 0.72% | 203,190 | $-2,865 | |||
| LAB Standard BioTools Inc. - Common Stock | $21,470 | 0.15% | 16,515 | $1,652 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| HLVX | Sept. 30, 2025 | 6,724,000 | $13,381,160 | No longer tracked |
| TSBX | Sept. 30, 2025 | 895,824 | $321,601 | No longer tracked |
| THRD | Sept. 30, 2025 | 36,835 | $200,014 | No longer tracked |